GHRH receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-02-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C152H252N44O42 | Cited for the form without the drug affinity complex |
| Molecular weight | About 3368 Da | Reported value for modified GRF(1-29) |
| Appearance | White to off-white powder | Lyophilised solid as usually supplied |
| Solubility | Soluble in water and polar solvents | Clarity depends on purity and salt content |
| Typical storage | -20 C or below, dry | Protect from light and repeated warming cycles |
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
Purity is most often assessed by reversed-phase high-performance liquid chromatography, reported as a percentage of total peak area. Identity is confirmed by mass spectrometry, which yields a molecular ion consistent with the expected sequence. Amino acid analysis and peptide mapping provide additional characterization. Reported purity values are method-dependent, so figures from different laboratories are not always directly comparable without details of column, gradient, and detection wavelength.
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Another major biological process and target of many chemotherapeutic drugs is the disruption of structures and genes involved in DNA replication, which would aim to reduce cancer cell proliferation and survival. However, through gene amplification, a resistance-inducing mechanism in which multiple copies of a gene are produced by cancer cells, the enhanced quantity of gene copy number limit the efficiency of such drugs, therefore allowing cancer cells to restore their proliferative ability and promote uncontrolled cell growth. A target enzyme known as topoisomerase II (Topo II) recognized for its fundamental role in detangling and repairing DNA, has also been proposed as a potentially promising site of action for drugs designed to induce DNA breakage. Here, it was suggested that the inhibition of Topo II would result in enzyme-mediated DNA breakage which without the proper functioning of repairment, would ultimately induce cell stress and apoptosis, or programmed cell death. As resistance to these Topo II poisons emerged, it was determined that cancer cells had developed mechanisms to reduce the expression of the Topo II enzyme, ultimately depriving these drugs from their targets and rendering them ineffective. Cancer cells have developed other resistance mechanisms to mediate the effects of chemotherapy-induced DNA breakage such as the activation of DNA damage repair (DDR) pathways which may recruit and upregulate various genes involved in DNA repair processes, thus countering the effects of many chemotherapeutic drugs.
== Sequence == The Kozak sequence was determined by sequencing of 699 vertebrate mRNAs and verified by site-directed mutagenesis. While initially limited to a subset of vertebrates (i.e. human, cow, cat, dog, chicken, guinea pig, hamster, mouse, pig, rabbit, sheep, and Xenopus), subsequent studies confirmed its conservation in higher eukaryotes generally. The sequence was defined as 5'-(gcc)gccRccAUGG-3' (IUPAC nucleobase notation summarized here) where:
== Role of smoking == To date, all reported patients with SRIF have been heavy current smokers or ex-smokers, lending credence to the assertion that this condition is caused by smoking. There are no published reports of SRIF in never-smokers.
In 2025, Willis underwent keyhole heart surgery after medical investigations revealed that she had a congenital hole in her heart which she had been unaware of for 48 years. The condition was discovered following routine checks and further investigation after an MRI scan identified an enlargement in her heart. Willis underwent the procedure at the Royal Brompton Hospital and later publicly thanked the medical staff who treated her.
In 2007, she appeared opposite Milla Jovovich in Resident Evil: Extinction, portraying Claire Redfield, who in the film, is the leader of a convoy of zombie apocalypse survivors going to Alaska in search of a safe haven. Her role sent her to Mexicali, Mexico for filming from May to late July, and required her hair to be dyed a light red. Speaking about her character Claire, Larter said, "She became the leader of this convoy. She's incredibly strong, patient. I think she serves a role for everyone within this convoy, let it be a mother to someone, a buddy, a best friend." Despite negative reviews, the film made $147 million worldwide. Also in the same year, she appeared with Hayes MacArthur in the comedy Homo Erectus and appeared as Evelyn Garland in the biographical drama Crazy, based on guitarist Hank Garland. Larter starred opposite Beyoncé and Idris Elba from London, in the Screen Gems-produced thriller Obsessed (2009). The film follows an office executive Derek Charles (Elba) whose marriage to Knowles' character Sharon is threatened by the aggressive interests of a co-worker Lisa Sheridan, portrayed by Larter. In an interview with Glam, Larter said that she "was excited to get the chance to play a femme fatale. I love playing women that are dark and vulnerable and sort of filled with a little bit of crazy emotion." While the film was released to mixed reviews, Larter was critically praised for her performance.
Sources: en.wikipedia.org
== Tissue distribution == Type III collagen is found as a major structural component in hollow organs such as large blood vessels, uterus and bowel. It is also found in many other tissues together with type I collagen.
=== Cold fusion === 208Pb(48Ca,xn)256−xNo (x=1,2,3,4) This cold fusion reaction was first studied in 1979 at Flerov Laboratory of Nuclear Reactions (FLNR). Further work in 1988 at GSI measured EC and SF branchings in 254No. In 1989, the FLNR used the reaction to measure SF decay characteristics for the two isomers of 254No. The measurement of the 2n excitation function was reported in 2001 by Yuri Oganessian at the FLNR. Patin et al. at the LBNL reported in 2002 the synthesis of 255–251No in the 1-4n exit channels and measured further decay data for these isotopes. The reaction has recently been used at Jyväskylän Yliopisto Fysiikan Laitos (JYFL) using the RITU set-up to study K-isomerism in 254No. The scientists were able to measure two K-isomers with half-lives of 275 ms and 198 s, respectively. They were assigned to 8− and 16+ K-isomeric levels. The reaction was used in 2004–5 at the FLNR to study the spectroscopy of 255–253No. The team were able to confirm an isomeric level in 253No with a half-life of 43.5 s.
==== Dismantling clean energy initiatives ==== The nonpartisan think tank Energy Innovation found that the bill's efforts to dismantle clean energy incentives would cost more than 830,000 jobs across the country. Cutting clean energy incentives would also raise energy costs for households, with wholesale power prices rising by roughly fifty percent by 2035 due to the loss of new generation capacity.
== Magnet programs and centers == Magnet programs were first implemented in PGCPS in 1985, to fulfill a court-ordered desegregation mandate. Up until as late as the late 80s, Prince George's County had been predominantly white in terms of racial demographics. In order to desegregate mostly all-White schools in the school system, PGCPS created several magnet programs that eventually were instituted in over fifty schools, spread throughout the county. By the late 1990s, the population demographics of the county had shifted towards a mostly African American majority. Magnet programs (as they were set up) were costing PGCPS approximately $14 million per year, to operate. The programs were costly and this was exacerbated by the fact that the school system's operating budget was greater than the final budget the school system had traditionally been allotted, an issue that had plagued the school system for years. Since the county's population now primarily consisted of African Americans, and due to the expense of operating the Magnet Schools Program, courts began to investigate the justification of PGCPS's magnet program. In 2004, a court ruled to discontinue court-ordered busing which had existed in the county, for over 30 years, based primarily on the fact that desegregation was no longer an issue in the predominantly Black Prince George's County. With the ending of the court-ordered busing, also came changes to the school system's Magnet Schools Program. The program had gained national attention, as it was one of the largest in the country.
In March 2025, German Doner Kebab (GDK) opened its first Cambridge location at the Cambridge Services on the A14 at Junction 24. In May 2025, German Doner Kebab (GDK) opened its first Norwich location at 43 St Stephens Street, and a new restaurant in Kent at Bluewater Shopping Centre.
Sources: en.wikipedia.org
== Medical uses == Sumatriptan is indicated for the acute treatment of migraine with or without aura in adults; or the acute treatment of cluster headache in adults. Sumatriptan is effective for ending or relieving the intensity of migraine and cluster headaches. Injected sumatriptan is more effective than other formulations. Oral sumatriptan can be used also in the treatment of post-dural puncture headache.
== Neuroendocrine regulation of behavior == Social behavior, reproductive behavior, moods, feelings, attitudes, development and survival are affected by the neuroendocrine system and studied in the field of behavioral endocrinology. One perspective views hormones as biological “coordinators”, responding to various “inputs” by appropriately regulating the related “outputs”. For example, androgens such as testosterone, estradiol and progesterone modulate the investment of resources spent toward mating or survival. From this perspective, the androgens respond to several relevant inputs (the presence of potential mates, the amount of food or fat available, stress, illness, etc,) and modulates physiology and behavior accordingly (modulating metabolic rate and fat storage, courtship behavior, parental behavior, etc.)
== Sovereign Principality of the United Netherlands (1813–1815) == Following the collapse of the Napoleonic regime, and allied forces drove out the French in 1813, the Dutch called back William Frederick, the son of the last stadtholder William V, to head the new government. He was proclaimed "sovereign prince" and the country briefly existed as the Sovereign Principality of the United Netherlands.
== Early life and education == Born in Preston, Lancashire in 1949, Halliwell was educated at Preston Grammar School. He attended St Catherine's College, University of Oxford (1968–71), achieving a BA with First Class (honours) in biochemistry. He was also awarded the Rose Prize for the best final papers of any candidate in biological sciences. His D.Phil in plant biochemistry was also at Oxford, supervised by Frederick R. Whatley and Vernon Butt; his thesis was entitled "The biochemistry of plant peroxisomes" (1973). He was later awarded a D.Sc from the University of London for his work on the biochemistry of free radical reactions in plant and animal systems.
At least eleven films have held the record of 'highest-grossing film' since The Birth of a Nation assumed the top spot in 1915. Both The Birth of a Nation and Gone with the Wind spent twenty-five consecutive years apiece as the highest-grosser, with films directed by Steven Spielberg and James Cameron holding the record on three occasions each. Spielberg became the first director to break his own record when Jurassic Park overtook E.T., and Cameron emulated the feat when Avatar broke the record set by Titanic. When it took over the top spot in 2019, Avengers: Endgame became the first sequel to hold the record of highest-grossing film, and in doing so interrupted thirty-six years of Spielberg/Cameron dominance before Avatar reclaimed the top spot two years later in 2021 upon a re-release. Some sources claim that The Big Parade superseded The Birth of a Nation as highest-grossing film, eventually being replaced by Snow White and the Seven Dwarfs, which in turn was quickly usurped by Gone with the Wind. Exact figures are not known for The Birth of a Nation, but contemporary records put its worldwide earnings at $5.2 million as of 1919. Its international release was delayed by World War I, and it was not released in many foreign territories until the 1920s; coupled with further re-releases in the United States, its $10 million earnings as reported by Variety in 1932 are consistent with the earlier figure.
Sources: en.wikipedia.org
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.
No regulatory agency has approved CJC-1295 for clinical use. Human trials were conducted in the 2000s, but the development programme was discontinued before any marketing application succeeded. Material sold today is offered as a research chemical, and its purity depends on the supplier.
Sermorelin is an unmodified fragment of growth hormone-releasing hormone and is cleared quickly. CJC-1295 contains substitutions that resist breakdown, and the form with a drug affinity complex persists much longer. Both act at the same receptor but differ substantially in duration of action.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.